FDA approves anemia drug for cats with chronic kidney disease
AVMA News
MAY 9, 2023
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive conditional approval from the Food and Drug Administration (FDA).
Let's personalize your content